U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C30H32O9
Molecular Weight 536.5697
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SCHISANTHERIN A

SMILES

COC1=C(OC)C(OC)=C2C(=C1)[C@H](OC(=O)C3=CC=CC=C3)[C@@](C)(O)[C@@H](C)CC4=C2C(OC)=C5OCOC5=C4

InChI

InChIKey=UFCGDBKFOKKVAC-DSASHONVSA-N
InChI=1S/C30H32O9/c1-16-12-18-13-21-25(38-15-37-21)26(35-5)22(18)23-19(14-20(33-3)24(34-4)27(23)36-6)28(30(16,2)32)39-29(31)17-10-8-7-9-11-17/h7-11,13-14,16,28,32H,12,15H2,1-6H3/t16-,28-,30-/m0/s1

HIDE SMILES / InChI
Schisantherin A is a dibenzocyclooctadiene originally found in Schisandra that exhibits anti-tussive, sedative, anti-inflammatory, anti-osteoporotic, neuroprotective, cognition enhancing, and cardioprotective activities. In macrophages, schisantherin A decreases LPS-induced expression and activity of iNOS, COX-2, NO, IL-6, and TNF-α. Schisantherin A also decreases RANKL-induced NF-κB signaling by inhibiting IκBα degradation and suppressing JNK and ERK1/2 activation in vitro; it also inhibits osteoclast function and bone erosion in vivo. In animal models of Alzheimer’s disease, schisantherin A inhibits amyloid-β (Aβ)-induced learning and memory impairments in Y maze, shuttle box, and Morris water maze assays. Additionally, this compound lowers left ventricular systolic and end diastolic pressures, decreases infarct size and maldionaldehyde release, and increases superoxide dismutase activity, preventing myocardial apoptosis in animal models of cardiac ischemia/reperfusion. Schisantherin A conferred significant protection against MPTP-induced loss of TH-positive dopaminergic neurons in a Parkinson's disease (PD) mice model. Western blotting analysis demonstrated that Schisantherin A exhibited neuroprotection against MPP(+) through the regulation of two distinct pathways including increasing CREB-mediated Bcl-2 expression and activating PI3K/Akt survival signaling suggesting that StA might be a promising neuroprotective agent for the prevention of PD.

CNS Activity

Curator's Comment: Schisantherin A conferred significant protection against MPTP-induced loss of TH-positive dopaminergic neurons in a Parkinson's disease (PD) mice model.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
12.5 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Preventing
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Schisantherin A attenuates ischemia/reperfusion-induced neuronal injury in rats via regulation of TLR4 and C5aR1 signaling pathways.
2017 Nov
Patents

Sample Use Guides

Schisantherin A at different concentrations (30, 100 or 300 mg/kg/day) was administered by intragastric gavage (i.g.), daily for 14 days
Route of Administration: Other
To investigate the contribution of the PI3K/Akt pathway to the neuroprotective effects of Schisantherin A (StA), phosphorylation-Akt (p-Akt) levels following pre-treatment with 60 uM StA for 12 h, and subsequent exposure to 2 mM MPP+ for a further 36 h were measured. StA treatment alone could up-regulate p-Akt levels 2.5-fold level compared with the control group.
Name Type Language
SCHISANTHERIN A
Common Name English
SCHIZANTHERIN A
Common Name English
SCHISANTHERIN A (GOMISIN C) (CONSTITUENT OF NORTHERN SCHISANDRA) [DSC]
Common Name English
GOMISIN C
Common Name English
BENZO(3,4)CYCLOOCTA(1,2-F)(1,3)BENZODIOXOLE-5,6-DIOL, 5,6,7,8-TETRAHYDRO-1,2,3,13-TETRAMETHOXY-6,7-DIMETHYL-, 5-BENZOATE, (5S,6S,7S,13AS)-
Systematic Name English
Code System Code Type Description
FDA UNII
873480KS4A
Created by admin on Fri Dec 15 15:59:08 GMT 2023 , Edited by admin on Fri Dec 15 15:59:08 GMT 2023
PRIMARY
CAS
58546-56-8
Created by admin on Fri Dec 15 15:59:08 GMT 2023 , Edited by admin on Fri Dec 15 15:59:08 GMT 2023
PRIMARY
PUBCHEM
151529
Created by admin on Fri Dec 15 15:59:08 GMT 2023 , Edited by admin on Fri Dec 15 15:59:08 GMT 2023
PRIMARY
EPA CompTox
DTXSID70207261
Created by admin on Fri Dec 15 15:59:08 GMT 2023 , Edited by admin on Fri Dec 15 15:59:08 GMT 2023
PRIMARY